Government backing cuts investor risk

Article Excerpt

Both Calian and WELL Health offer investors a major plus. Specifically, the two get most of their revenue from governments. For Calian, revenue generated from federal departments and agencies currently represents about 50% of the total. Meanwhile, WELL profits from Canada’s government-backed, recession-resilient health-care sector. CALIAN GROUP, $63.39, is a buy. The stock (Toronto symbol CGY; TSINetwork Rating: Extra Risk) (calian.com; Shares outstanding: 11.7 million; Market cap: $736.7 million; Dividend yield: 1.8%) lets investors tap the Ottawa-based company’s four main operating segments: Advanced Technologies offers products and engineering services for the space, communications, nuclear, agriculture, defence and government sectors. The Health unit manages a network of more than 1,800 healthcare professionals delivering primary care and occupational health services to public- and private-sector clients across Canada. The Learning division provides specialized training services and solutions for the Canadian Armed Forces and others. And Information Technology provides support for delivering complex IT and cybersecurity solutions. In the quarter ended December 31, 2022, revenue rose 19.9%, to $147.5 million from $129.5 million a year earlier. Excluding one-time…